Velocity Clinical Research - Savannah — Savannah, Georgia

Velocity Clinical Research - Savannah is a clinical research site located in Savannah, Georgia, United States 31406.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research - Savannah has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Painful Lumbosacral Radiculopathy, SARS-CoV2, COVID-19.

Sponsors: Vertex Pharmaceuticals Incorporated, Vaxart, Bayer.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research - Savannah?

Velocity Clinical Research - Savannah has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research - Savannah conducted?

Velocity Clinical Research - Savannah has 4 clinical trials on record, with 2 currently active. Their work covers Painful Lumbosacral Radiculopathy, SARS-CoV2, COVID-19.

Is Velocity Clinical Research - Savannah accredited by Crixeo Health?

Yes — Velocity Clinical Research - Savannah holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research - Savannah?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.